> top > docs > PubMed:20528871 > annotations

PubMed:20528871 JSONTXT

Annnotations TAB JSON ListView MergeView

TEST-DiseaseOrPhenotypicFeature

Id Subject Object Predicate Lexical cue #label
T1 120-129 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T2 134-142 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T3 363-372 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T4 376-384 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T5 496-516 DiseaseOrPhenotypicFeature denotes musculoskeletal pain D059352
T6 533-541 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T7 981-989 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

TEST-ChemicalEntity

Id Subject Object Predicate Lexical cue ID:
T1 21-31 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612
T2 33-42 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T4 48-64 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T7 168-178 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612
T8 198-207 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T10 217-233 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T13 235-238 ChemicalEntity denotes CPM D003520
T14 835-838 ChemicalEntity denotes CPM D003520
T15 927-936 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T17 941-957 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026

TEST-OrganismTaxon

Id Subject Object Predicate Lexical cue
T1 697-705 OrganismTaxon denotes patients
T2 1006-1015 OrganismTaxon denotes monitored

Test-merged

Id Subject Object Predicate Lexical cue #label ID:
T7 981-989 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T6 533-541 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T5 496-516 DiseaseOrPhenotypicFeature denotes musculoskeletal pain D059352
T4 376-384 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T3 363-372 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T2 134-142 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T1 120-129 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T50401 1006-1015 OrganismTaxon denotes monitored
T43758 697-705 OrganismTaxon denotes patients
T17 941-957 ChemicalEntity denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520
T15 927-936 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T14 835-838 ChemicalEntity denotes CPM D003520
T13 235-238 ChemicalEntity denotes CPM D003520
T10 217-233 ChemicalEntity denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520
T8 198-207 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T41943 168-178 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612
T88894 48-64 ChemicalEntity denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027|D003520
T17186 33-42 ChemicalEntity denotes etoposide http://purl.obolibrary.org/obo/CHEBI_4911|D005047
T12540 21-31 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612

Test-merged-2

Id Subject Object Predicate Lexical cue #label ID:
T12540 21-31 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612
T17186 33-42 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T88894 48-64 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T41943 168-178 ChemicalEntity denotes nelarabine http://purl.obolibrary.org/obo/CHEBI_63612
T8 198-207 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T10 217-233 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T13 235-238 ChemicalEntity denotes CPM D003520
T14 835-838 ChemicalEntity denotes CPM D003520
T15 927-936 ChemicalEntity denotes etoposide D005047|http://purl.obolibrary.org/obo/CHEBI_4911
T17 941-957 ChemicalEntity denotes cyclophosphamide D003520|http://purl.obolibrary.org/obo/CHEBI_4027|http://purl.obolibrary.org/obo/CHEBI_4026
T43758 697-705 OrganismTaxon denotes patients
T50401 1006-1015 OrganismTaxon denotes monitored
T1 120-129 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T2 134-142 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T3 363-372 DiseaseOrPhenotypicFeature denotes leukaemia DISEASE
T4 376-384 DiseaseOrPhenotypicFeature denotes lymphoma D008223
T5 496-516 DiseaseOrPhenotypicFeature denotes musculoskeletal pain D059352
T6 533-541 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T7 981-989 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 376-384 HP_0002665 denotes lymphoma
T2 512-516 HP_0012531 denotes pain

Allie

Id Subject Object Predicate Lexical cue
SS1_20528871_1_0 217-233 expanded denotes cyclophosphamide
SS2_20528871_1_0 235-238 abbr denotes CPM
AE1_20528871_1_0 SS1_20528871_1_0 SS2_20528871_1_0 abbreviatedTo cyclophosphamide,CPM